| Wissenschaftl. Titel | "MATAO MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancer: a randomized double-blinded placebo-controlled multi-center phase III Trial (ENGOT-ov54/Swiss-GO-2/MATAO) including LOGOS (Low Grade Ovarian cancer Sub-study)" |
| Erkrankung |
Gyn:
Ovarialkarzinom:
Erstlinie
|
| Kurzprotokoll | Kurzprotokoll |
| Links | Weiterführende Informationen (EudraCT) |
erstellt 25.04.2024 Data entry III CCP
geändert 25.04.2024 Data entry III CCP